CORC

在结果中检索

CORC

浏览/检索结果: 共68条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway 期刊论文
JOURNAL OF ETHNOPHARMACOLOGY, 2019, 卷号: 234
作者:  Zhu, Yangzhuangzhuang;  Zhang, Fei;  Liu, Fei;  Chen, Xiao;  Wei, Luyao
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05
Traditional Chinese Medicine Treatment as Adjuvant Therapy in Completely Resected Stage IB-IIIA Non-Small-Cell Lung Cancer: Study Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial 期刊论文
CLINICAL LUNG CANCER, 2019, 卷号: 20, 期号: 5
作者:  Jiang, Yi;  Liu, Ling-shuang;  Shen, Li-ping;  Liu, Jia-xiang;  Jiang, Ge-ning
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Effects of ginsenoside Rg3 combined with I-125 seeds on serum TGF-alpha, TGF-beta 1, and VEGF in patients with medium and advanced non-small cell lung cancer 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 卷号: 12, 期号: 2
作者:  Zhang, Zeliang;  Zhang, Kun;  Yu, Qiquan;  Shou, Weizhen
收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05
Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China 期刊论文
LUNG CANCER, 2019, 卷号: 127
作者:  Gu, Xiaohua;  Zhang, Qiang;  Chu, Yun-Bo;  Zhao, Yi-Yang;  Zhang, Yan-Jun
收藏  |  浏览/下载：14/0  |  提交时间：2019/12/05
Jingfukang induces anti-cancer activity through oxidative stress-mediated DNA damage in circulating human lung cancer cells 期刊论文
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 卷号: 19, 期号: 1
作者:  Que, Zujun;  Zhou, Zhiyi;  Luo, Bin;  Dong, Changsheng;  Jiang, Yi
收藏  |  浏览/下载：30/0  |  提交时间：2019/12/05
HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway 期刊论文
ONCOTARGETS AND THERAPY, 2019, 卷号: 12
作者:  He, Saifei;  Ma, Xing;  Ye, Ying;  Zhang, Miao;  Zhuang, Juhua
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Yuan, Man;  Xu, Lin-feng;  Zhang, Juan;  Kong, Si-yuan;  Wu, Man
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis 期刊论文
BMC CANCER, 2019, 卷号: 19
作者:  Zhou, Min;  Sun, Xiaoying;  Roudi, Raheleh;  Dai, Ting;  Chen, Shangya
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
LK7 increased NK-cell mediated lysis of non-small cell lung cancer cells by down-regulating CD155 and CD112 期刊论文
EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 卷号: 49
作者:  Wang, L.;  Zhu, X.;  Zhu, S.;  Ng, W.;  Yao, C.
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05
Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line 期刊论文
FRONTIERS IN ONCOLOGY, 2019, 卷号: 9
作者:  Zhang, Bo;  Lu, Jun;  Shi, Qin;  Zhang, Lele;  Wu, Jun
收藏  |  浏览/下载：18/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace